Prospective Validation of a Points Score System Predicting 30-day Survival

RecruitingOBSERVATIONAL
Enrollment

114

Participants

Timeline

Start Date

September 12, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Metastatic Cancer
Interventions
DIAGNOSTIC_TEST

Point score prediction tool for 30-day survival

"This tool requires laboratory data including white blood cell count, neutrophil-lymphocyte ratio, blood urea nitrogen, bilirubin, albumin, lactate dehydrogenase, and red cell distribution, as well as number of attendances to the emergency room in the past 100 days, the site receiving radiation therapy, and the primary cancer type. Each data point correlates with a point value, which are tallied to generate a final score.~The scores range from 0-20, with 0 giving the highest chance for survival at 30 days and 20 giving the lowest chance for survival at 30 days"

Trial Locations (3)

46032

RECRUITING

IU Health North / Schwarz Cancer Center, Carmel

46123

RECRUITING

IU Health West, Avon

46202

RECRUITING

Methodist Hospital, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER